EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
D003029:Coagulants; D003276:Contraceptives, Oral; D003850:Deoxyribonuclease I; D004791:Enzyme Inhibitors; D004997:Ethinyl Estradiol; D005260:Female; D005340:Fibrinogen; D005341:Fibrinolysin; D005342:Fibrinolysis; D006490:Hemostatics; D006801:Humans; D009641:Norethynodrel; D010600:Pharmacology; D010827:Physiology; D010958:Plasminogen; D012712:Serum Globulins; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D014116:Toxicology
D003029:Coagulants; D003276:Contraceptives, Oral; D004791:Enzyme Inhibitors; D006490:Hemostatics; D012712:Serum Globulins; D004997:Ethinyl Estradiol; D009641:Norethynodrel; D005340:Fibrinogen; D010958:Plasminogen; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin
ENZYME INHIBITORS; ETHINYL ESTRADIOL; FIBRINOGEN; FIBRINOLYSIN; FIBRINOLYSIS; NORETHYNODREL; PHARMACOLOGY; PHYSIOLOGY; PLASMINOGEN; SERUM GLOBULINS; STREPTODORNASE AND STREPTOKINASE; TOXICOLOGIC REPORT